Silicon Labs Q2 2026 results show growth; TI merger impact
Aug 11, 2026, 4:05 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
The TI deal creates optionality: if closing on schedule, synergies and scale could lift earnings power and multiple; delays or regulatory hurdles could weigh on value. Historically, pending mega-mergers can drive volatility with upside if near-term catalysts align.
AI summary
What happened, with direct paths to the underlying reporting
Silicon Labs posted Q2 2026 revenue of $228 million, up 18% year over year, with GAAP gross margin of 61.6% and non-GAAP 61.9%. The company suspended guidance amid its pending Texas Instruments merger. The TI deal could be a near-term price driver, with potential upside from design wins and margin leverage but execution and regulatory risks remain.
Q2 revenue $228M, up 18% YoY; gross margin around 61.6%.
Non-GAAP EPS $0.71; GAAP loss per share $(0.32).
TI acquisition announced; guidance suspended pending closing.
Medical revenue up 78% YoY; bookings and design wins accelerated.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event